Showing 991-1000 of 3019 results for "".
Psoriasis Treatment Redefined: Exploring the Impact of IL-23 Inhibitors
https://practicaldermatology.com/programs/dermconsult/psoriasis-treatment-redefined-exploring-the-impact-of-il-23-inhibitors/15836/How do IL-23 inhibitors play a role in treating moderate to severe psoriasis? Join us to find out more.From Pathophysiology to Therapeutic Progress: TYK2's Significance in Plaque Psoriasis
https://practicaldermatology.com/programs/dermconsult/from-pathophysiology-to-therapeutic-progress-tyk2s-significance-in-plaque-psoriasis/15835/How can our understanding of TYK2 help us better treat our patients with moderate-to-severe plaque psoriasis? Join us to find out.DermWireTV: Skin Cancer Foundation’s Big See, Cosmetic Consumer Insights, Cosmetic Bootcamp Recap
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-skin-cancer-foundation-confronts-the-big-see-cosmetic-consumer-insights/19632/The Skin Cancer Foundation’s new multiyear public service campaign, “The Big See," urges proactive approaches to skin cancer diagnosis. Results of the Synchrony Financial Cosmetic Path to Purchase Research Study show that 8 in 10 cosmetic consumers said they researched a procedure or treatment befoPearls for Monitoring and Managing Itch: An Expert Panel
https://practicaldermatology.com/topics/atopic-dermatitis/pearls-for-monitoring-and-managing-itch-an-expert-panel/26999/Pearls for Monitoring and Managing Itch: An Expert PanelPruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
https://practicaldermatology.com/programs/cme/pruritus-cases-from-the-field-real-world-perspectives-on-managing-ckd-ap/14969/Did you know that many patients on dialysis suffer from itch, or pruritus? Hear patients describe their experiences with a new FDA-approved therapy.Vitiligo Uncovered: Exploring the Latest Advances in Treatment and Care
https://practicaldermatology.com/youngmd-connect/ymdc-workshops/vitiligo-uncovered-exploring-latest-advances-treatment-and-care/29519/In this on-demand webinar, Dr. Domingues and Dr. Silverberg provide a comprehensive overview of vitiligo. This session covers the various types of vitiligo, essential patient evaluation techniques, and understanding disease progression. Learn about treatment strategies from both private practice andPurified Botulinum Toxin Type A Complex for Bilateral Palmar Hyperhidrosis: A Case Report and Literature Review
https://practicaldermatology.com/programs/practical-dermatology/purified-botulinum-toxin-type-a-complex-for-bilateral-palmar-hyperhidrosis-a-case-report-literature-review/23984/A 40-year-old Caucasian woman presented to the clinic for persistent sweating of the bilateral hands, including the volar surface of the hand extending to the respective surfaces of the digits beginning approximately 20 years ago. Unsuccessful prior therapies include antiperspirants, the use of an iPoster Pearl: Itch Control Matters Most to Patients with Moderate-to-Severe Atopic Dermatitis
https://practicaldermatology.com/programs/dermconsult/poster-pearl-itch-control-matters-most-to-patients-with-moderate-to-severe-atopic-dermatitis/15594/Dive into the findings from a poster featured at the 2023 Fall Clinical Dermatology conference.DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesDirected Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
https://practicaldermatology.com/programs/cme/directed-relief-in-ckd-ap-linking-targeted-therapy-to-clinical-outcomes/14967/Join our experts’ discussion to learn how to significantly improve quality of life for your patients with chronic kidney disease-associated pruritus.